WFG Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1
Closed 1688
2017
Q1
$0 Hold
1
﹤0.01% 1693
2016
Q4
$0 Hold
1
﹤0.01% 1760
2016
Q3
$0 Hold
1
﹤0.01% 1713
2016
Q2
$0 Hold
1
﹤0.01% 1714
2016
Q1
$0 Hold
1
﹤0.01% 1707
2015
Q4
$0 Hold
1
﹤0.01% 1689
2015
Q3
$0 Hold
1
﹤0.01% 1731
2015
Q2
$0 Hold
1
﹤0.01% 1828
2015
Q1
$0 Hold
1
﹤0.01% 2112
2014
Q4
$0 Hold
1
﹤0.01% 2262
2014
Q3
$0 Hold
1
﹤0.01% 2181
2014
Q2
$0 Hold
1
﹤0.01% 2085
2014
Q1
$0 Sell
1
-3
-75% -$40 ﹤0.01% 2261
2013
Q4
$0 Hold
4
﹤0.01% 2335
2013
Q3
$0 Hold
4
﹤0.01% 2269
2013
Q2
$0 Buy
+4
New +$42 ﹤0.01% 2118

Other funds holding CDMO

WFG Advisors's CDMO Position: Q2 2017 in Review

WFG Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2017, closing a stake of 1 share.

WFG Advisors first reported a position in CDMO in Q2 2013 and held it in 16 quarters. The position peaked at $0 in Q1 2017. 60 funds tracked by Wall St. Rank hold CDMO as of Q2 2017.

  • WFG Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • WFG Advisors sold 1 Avid Bioservices, Inc. Common Stock share in Q2 2017.
  • WFG Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • WFG Advisors's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q1 2017.
  • 60 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.